These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 32827561)
1. The integrated use of in silico methods for the hepatotoxicity potential of Piper methysticum. Tugcu G; Kırmızıbekmez H; Aydın A Food Chem Toxicol; 2020 Nov; 145():111663. PubMed ID: 32827561 [TBL] [Abstract][Full Text] [Related]
2. Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats. Lim ST; Dragull K; Tang CS; Bittenbender HC; Efird JT; Nerurkar PV Toxicol Sci; 2007 May; 97(1):214-21. PubMed ID: 17329236 [TBL] [Abstract][Full Text] [Related]
3. Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical and clinical studies based on a review of the evidence. Teschke R; Qiu SX; Xuan TD; Lebot V Phytother Res; 2011 Sep; 25(9):1263-74. PubMed ID: 21442674 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro, reactivity, and identification of 6-phenyl-3-hexen-2-one in human urine after kava-kava (Piper methysticum) ingestion. Zou L; Harkey MR; Henderson GL Planta Med; 2005 Feb; 71(2):142-6. PubMed ID: 15729622 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.). Anke J; Ramzan I J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747 [TBL] [Abstract][Full Text] [Related]
16. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward? Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850 [TBL] [Abstract][Full Text] [Related]
17. In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones. Nerurkar PV; Dragull K; Tang CS Toxicol Sci; 2004 May; 79(1):106-11. PubMed ID: 14737001 [TBL] [Abstract][Full Text] [Related]
18. Biological Activity, Hepatotoxicity, and Structure-Activity Relationship of Kavalactones and Flavokavins, the Two Main Bioactive Components in Kava ( Wang Y; Su C; Zhang B; Niu Y; Ren R; Zhao X; Yang L; Zhang W; Ma X Evid Based Complement Alternat Med; 2021; 2021():6851798. PubMed ID: 34471418 [TBL] [Abstract][Full Text] [Related]
19. Constituents in kava extracts potentially involved in hepatotoxicity: a review. Olsen LR; Grillo MP; Skonberg C Chem Res Toxicol; 2011 Jul; 24(7):992-1002. PubMed ID: 21506562 [TBL] [Abstract][Full Text] [Related]
20. Liver transplantation and the use of KAVA: Case report. Becker MW; Lourençone EMS; De Mello AF; Branco A; Filho EMR; Blatt CR; Mallmann CA; Schneider M; Caregnato RCA; Blatt CR Phytomedicine; 2019 Mar; 56():21-26. PubMed ID: 30668342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]